Skip to content
Subscriber Only
Business
Economics

Pfizer Destroyed Arthritis Drugs’ Files, Investors Claim

Pfizer Inc. destroyed documents about the development of its Celebrex and Bextra arthritis drugs while denying the existence of electronic databases containing millions of files about the medicines, lawyers for some of the company’s investors said in court filings.

Pfizer officials should be sanctioned for denying they had a centralized filing system for Celebrex and Bextra files and discarding records after investors filed suit accusing the company of misleading them about the drugs’ prospects, shareholders’ attorneys said in a court filing that was unsealed Nov. 16 in federal court in Manhattan. Pfizer executives later acknowledged the company maintained more than 2,000 so-called e-Rooms that stored documents about the drugmaker’s products, the lawyers said.